Recent News for HEB - Hemispherx BioPharma, Inc.

Date Title
Jul 9 5 Immunotherapy Stocks to Keep a Close Eye On
Jul 2 Hemispherx Biopharma, Inc. Discusses Clinical Development and Competitive Advantage in New SNNLive Video Interview on
Jun 28 AG, WPX, HEB and KEG among notable after hour movers
Jun 28 Hemispherx Biopharma CFO Adam Pascale Announces Retirement
Jun 24 Have Insiders Been Buying Hemispherx Biopharma, Inc. (NYSEMKT:HEB) Shares?
Jun 21 Hemispherx Biopharma Inc (HEB) Exec. Vice Chairman/CEO/Pres. Thomas K. ...
Jun 17 ARRY, RIOT among premarket gainers
Jun 17 Hemispherx Biopharma Issues Clinical Update for Ampligen Immuno-oncology Program
Jun 14 Maxim pulls out two healthcare nuggets
Jun 13 Mid-Afternoon Market Update: Dow Rises 80 Points; Red Robin Shares Spike Higher
Jun 13 Microcaps mostly among midday movers
Jun 13 Mid-Day Market Update: Coda Octopus Group Surges After Strong Q2 Results; Arcadia Biosciences Shares Slide
Jun 13 Aeterna Zentaris and CEL-SCI among healthcare gainers; Savara leads the losers
Jun 13 Company News For Jun 13, 2019
Jun 13 SVRA and HEB among premarket losers
Jun 13 How Does Investing In Hemispherx Biopharma, Inc. (NYSEMKT:HEB) Impact The Volatility Of Your Portfolio?
Jun 12 LULU, RH and TLRD among after hour movers
Jun 12 Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combination with Pembrolizumab and Cisplatin
Jun 12 The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana
Jun 11 PLAY leads after hours losers
Jun 11 Healthcare tops midday movers
Jun 11 48 Stocks Moving In Tuesday's Mid-Day Session
Jun 11 Hemispherx Bio up 18% after reverse stock split
Jun 8 Stocks To Watch: Chewy IPO, Lululemon And Tesla On Tap
Jun 7 The Daily Biotech Pulse: Vertex Bets Big On Gene-Editing Therapies, Sanofi Poaches Novartis For CEO Role, Relief In Europe for Endologix
Back to the Main HEB Page...